Trial intelligence / Profile preview

PRP plus Focal Shockwave Therapy for Erectile Dysfunction

2024-517248-73-00Phase 4Authorised

Sponsor
Boston Medical Group
Start
Aug 2024
Countries
1
01

Overview

Phase 4, single-arm trial of platelet-rich plasma in erectile dysfunction (ED), sponsored by Boston Medical Group. Primary endpoint: Change in IIEF-EF score between baseline and week 21. Planned start Aug 2024; status: authorised.

02

Drugs

platelet-rich plasma
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on 2024-517248-73-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-517248-73-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call